Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-23

Clinical Trial Update: Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures [NA]

View source ↗

Summary

The clinical trial evaluating the Auryzon devices for ear and nose reconstruction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Auryzon Device

Snippet

Sponsor: Reconstrata, LLC | Conditions: Ear Deformities, Acquired, Ear; Deformity, Congenital | NA | Status: TERMINATED